Schroder Investment Management Group
SAGE icon

Schroder Investment Management Group’s Sage Therapeutics SAGE Stock Holding History

Schroder Investment Management Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-52,076
Closed -$1.07M – 1264
2023
Q3 		$1.07M Sell
52,076
-98,228
-65% -$2.84M ﹤0.01% 1008
2023
Q2 		$7.07M Buy
150,304
+96,378
+179% +$4.79M 0.01% 711
2023
Q1 		$2.26M Sell
53,926
-3,460
-6% -$149K ﹤0.01% 932
2022
Q4 		$2.19M Buy
+57,386
New +$2.19M ﹤0.01% 928
2022
Q1 		– Sell
-143
Closed -$6K – 1554
2021
Q4 		$6K Buy
143
+59
+70% +$2.47K ﹤0.01% 1395
2021
Q3 		$4K Hold
84
– – ﹤0.01% 1476
2021
Q2 		$5K Sell
84
-30,315
-100% -$2.14M ﹤0.01% 1498
2021
Q1 		$2.27M Sell
30,399
-51,016
-63% -$4.18M ﹤0.01% 987
2020
Q4 		$7.04M Buy
81,415
+6,251
+8% +$461K 0.01% 725
2020
Q3 		$4.39M Buy
75,164
+14,611
+24% +$741K 0.01% 748
2020
Q2 		$2.52M Buy
60,553
+39,045
+182% +$1.42M ﹤0.01% 787
2020
Q1 		$610K Buy
+21,508
New +$1.25M ﹤0.01% 963
2019
Q4 		– Sell
-1,239
Closed -$177K – 1336
2019
Q3 		$177K Sell
1,239
-435
-26% -$72.8K ﹤0.01% 1157
2019
Q2 		$306K Sell
1,674
-346
-17% -$59K ﹤0.01% 1117
2019
Q1 		$321K Sell
2,020
-630
-24% -$91.2K ﹤0.01% 1038
2018
Q4 		$254K Sell
2,650
-151
-5% -$17.3K ﹤0.01% 1065
2018
Q3 		$396K Buy
2,801
+426
+18% +$65.8K ﹤0.01% 1052
2018
Q2 		$361K Buy
+2,375
New +$373K ﹤0.01% 1093

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schroder Investment Management Group's SAGE Position: Q4 2023 in Review

Schroder Investment Management Group sold out of Sage Therapeutics (SAGE) in Q4 2023, closing a stake of 52,076 shares — an estimated $1.07M sold.

Schroder Investment Management Group first reported a position in SAGE in Q2 2018 and held it in 18 quarters. The position peaked at $7.07M in Q2 2023. 201 funds tracked by Wall St. Rank hold SAGE as of Q4 2023.

  • Schroder Investment Management Group reported no remaining Sage Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 52,076 Sage Therapeutics shares in Q4 2023, an estimated $1.07M.
  • Schroder Investment Management Group first reported a position in Sage Therapeutics in Q2 2018 and held it in 18 quarters.
  • Schroder Investment Management Group's Sage Therapeutics position peaked at $7.07M in Q2 2023.
  • 201 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2023.

Based on Schroder Investment Management Group's 13F filing for Q4 2023, filed 14 Feb 2024.